ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.335
+0.025 (1.91%)
Oct 19, 2026, 12:40 PM EDT - Market open
ProQR Therapeutics Revenue
ProQR Therapeutics had revenue of 8.76M EUR in the quarter ending June 30, 2026, with 120.35% growth. This brings the company's total for the last twelve months to 18.42M, up 7.49% year-over-year. In the year 2025, ProQR Therapeutics had annual revenue of 16.35M, down -16.36%. That makes ProQR Therapeutics the 33,515th largest company in the world by revenue and 4,404th in the United States.
Revenue (ttm)
18.42M EUR
Revenue Growth
+7.49%
P/S Ratio
8.78
Revenue / Employee
98,730 EUR
Employees
187
Market Cap
188.40M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.35M | -3.20M | -16.36% |
| Dec 31, 2024 | 19.55M | 10.02M | 105.20% |
| Dec 31, 2023 | 9.53M | 5.17M | 118.51% |
| Dec 31, 2022 | 4.36M | 1.98M | 83.31% |
| Dec 31, 2021 | 2.38M | -7.07M | -74.84% |
| Dec 31, 2020 | 9.45M | 7.52M | 388.98% |
| Dec 31, 2019 | 1.93M | -3.83M | -66.45% |
| Dec 31, 2018 | 5.76M | 4.27M | 285.35% |
| Dec 31, 2017 | 1.50M | -333.00K | -18.22% |
| Dec 31, 2016 | 1.83M | -1.41M | -43.49% |
| Dec 31, 2015 | 3.24M | 2.92M | 933.55% |
| Dec 31, 2014 | 313.00K | 197.00K | 169.83% |
| Dec 31, 2013 | 116.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compugen | 74.00M |
| Invivyd | 58.37M |
| Sutro Biopharma | 45.70M |
| Alpha Cognition | 15.26M |
| Evommune | 10.00M |
| Camp4 Therapeutics | 4.22M |
| Cartesian Therapeutics | 1.48M |
| InflaRx | -11.54K |
PRQR News
- 4 days ago - ProQR Therapeutics management to meet with Oppenheimer - TheFly
- 6 days ago - ProQR Therapeutics management to meet with Oppenheimer - TheFly
- 18 days ago - ProQR price target lowered to $8 from $12 at H.C. Wainwright - TheFly
- 19 days ago - ProQR Therapeutics Transcript: Investor update - Transcripts
- 19 days ago - ProQR Therapeutics Slides: Investor update - Filings
- 19 days ago - ProQR Therapeutics Press release: Investor update - Filings
- 26 days ago - ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor - GlobeNewsWire
- 5 weeks ago - ProQR Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts